EnWave Chairman Wins LifeSciences B.C. Innovation & Achievement Award

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company")
today announced that LifeSciences British Columbia ("LSBC") has awarded Dr.
Timothy Durance, Chairman and Co-CEO of EnWave, with the 2012 Innovation &
Achievement Award for his development of EnWave's Radiant Energy Vacuum ("REV")
technology.


This award is presented annually by LSBC to recognize individuals and
organizations that have made outstanding contributions to the development of
British Columbia's life sciences industry across all sub-sectors, from
biopharmaceuticals and medical devices to bioproducts and bioenergy - sectors
which are critical to the economic future of the province and country.


"This year's award winners are outstanding," stated Don Enns, President of
LifeSciences BC. "British Columbia has some great leaders in biotech, and the
four individuals and one company selected for these awards are incredible
innovators. Our sector is world-class, and these winners represent significant
achievements resulting in economic growth for B.C."


"Over the past year, we have made significant technological advancements in
relation to the efficient dehydration of biopharmaceuticals," stated Dr.
Durance. "I am sincerely humbled by this noteworthy recognition. The innovation
and achievement that EnWave has accomplished thus far in the life sciences space
is very encouraging." 


The LifeSciences British Columbia Awards will be presented at a gala ceremony
the evening of Thursday, April 19th, 2012, in front of an audience of
approximately 600 guests representing the biopharmaceutical, medical device,
bioproducts, bioenergy and greater life sciences community at the Vancouver
Convention Centre.


About LifeSciences British Columbia 

LifeSciences British Columbia is a not-for-profit, non-government industry
association that represents and supports the biopharmaceutical, medical device,
bioproducts, bioenergy and greater life sciences community of British Columbia
through facilitation of partnering and investment, advocacy, education, and
promotion of our world-class science and industry. More information about
LifeSciences B.C. is available at http://www.lifesciencesbc.ca/. 


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV)
dehydration technology. In collaboration with an expanding list of multinational
partners, including Nestle, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray
Cranberries, Hormel, Bonduelle and Merck. EnWave is introducing REV as a new
dehydration standard in the food and biological material sectors: potentially
faster and cheaper than freeze drying, with better end product quality than air
drying or spray drying.


EnWave currently has six REV platforms: commercial-scale nutraREV(TM) and
MIVAP(TM) are used in the food industry to dry fruits, vegetables, meat, herbs
and seafood quickly and at low-cost, while maintaining high levels of nutrition,
taste, texture and colour. The Company is also developing powderREV(TM) for bulk
dehydration of food cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of pastes,
gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods
to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies.
More information about EnWave is available at www.enwave.net.


EnWave Corporation 

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures and
financial results are forward-looking statements. These statements are not a
guarantee of future performance and involve a number of risks, uncertainties and
assumptions. There is no guarantee that the Company's REV technology can or will
improve processes in the target industry; even if the Company's REV technology
can be used as described in this document, there is no guarantee that such use
will result in orders for the Company's REV technology. All figures comparing
REV technologies to freeze drying or other dehydration technologies are provided
as examples of data obtained through the Company's own scientific and testing
programs; each product must be tested individually to determine the benefits of
using REV.
(TSXV:REV)
過去株価チャート
から 5 2024 まで 6 2024